Precision medical biotechnology company Macrogen has been designated by the Ministry of Food and Drug Safety (MFDS) as a clinical trial specimen analysis institution, which performs specimen analysis of blood and urine collected from clinical test subjects.Macrogen can now perform next-generation se
Direct to customer (DTC) genetic testing companies are expanding their testing areas to diseases and diverse wellness fields on the back of the government’s “sandbox” deregulation initiative.The Ministry of Trade, Industry, and Energy designated three additional companies, DNA Link, Theragen Etex an
Hyundai Motor will set up hydrogen vehicle charging stations in three places in downtown Seoul, including one at the National Assembly.The station at the National Assembly has a capacity of 250 kg and is capable of charging more than 50 hydrogen vehicles a day. Hyundai Motor Co. is going to complete
SK Telecom announced on Aug. 21 that it has signed a business agreement with Macrogen, a precision medical biotechnology company, to develop a genome analysis solution based on artificial intelligence (AI).Genomic analysis is to identify DNA mutations, sequence information, and disease information.
Macrogen, a Korean precision medical company, announced on July 6 that it would build a blockchain-based genome big data distribution platform in cooperation with Bigster, a big data company.Macrogen decided to incorporate blockchain technology into the storage and transmission of genomic big data,
Macrogen announced on June 5 that the company established Macrogen Asia Pacific, a local corporation in Singapore.Macrogen Asia Pacific is Macrogen's second corporation in Asia, with the first one operating in Japan. The new corporation is located in Biopolis, a biomedical research park in Singa
An increasing number of South Korean pharmaceutical and biotech companies are setting up branches, joint ventures and subsidiaries abroad.Particularly successful examples include Hanmi Pharmaceutical’s Beijing Hanmi Pharmaceutical established in 1996 and Ilyang Pharmaceutical’s Yangzhou Ilyang Pharm
South Korean biotech and healthcare companies are rapidly expanding their business in Japan. For example, Macrogen recently established Macrogen Japan in Kyoto to provide a genome analysis service in the local market, which is expected to show a rapid growth led by the Japan Agency for Medical Resea